114 related articles for article (PubMed ID: 20978321)
1. Comparison of different promoter methylation assays in breast cancer.
Suijkerbuijk KP; Pan X; van der Wall E; van Diest PJ; Vooijs M
Anal Cell Pathol (Amst); 2010; 33(3):133-41. PubMed ID: 20978321
[TBL] [Abstract][Full Text] [Related]
2. Methylation pattern analysis in prostate cancer tissue: identification of biomarkers using an MS-MLPA approach.
Gurioli G; Salvi S; Martignano F; Foca F; Gunelli R; Costantini M; Cicchetti G; De Giorgi U; Sbarba PD; Calistri D; Casadio V
J Transl Med; 2016 Aug; 14(1):249. PubMed ID: 27576364
[TBL] [Abstract][Full Text] [Related]
3. A rapid and accurate closed-tube Methylation-Sensitive High Resolution Melting Analysis assay for the semi-quantitative determination of SOX17 promoter methylation in clinical samples.
Mastoraki S; Chimonidou M; Dimitrakopoulos L; Kounelis S; Malamos N; Georgoulias V; Lianidou E
Clin Chim Acta; 2015 Apr; 444():303-9. PubMed ID: 25727515
[TBL] [Abstract][Full Text] [Related]
4. Quantitation of DNA Methylation by Quantitative Multiplex Methylation-Specific PCR (QM-MSP) Assay.
Fackler MJ; Sukumar S
Methods Mol Biol; 2018; 1708():473-496. PubMed ID: 29224159
[TBL] [Abstract][Full Text] [Related]
5. Methylation-Specific Multiplex Ligation-Dependent Probe Amplification (MS-MLPA).
Moelans CB; Atanesyan L; Savola SP; van Diest PJ
Methods Mol Biol; 2018; 1708():537-549. PubMed ID: 29224162
[TBL] [Abstract][Full Text] [Related]
6. Quality assessment of DNA derived from up to 30 years old formalin fixed paraffin embedded (FFPE) tissue for PCR-based methylation analysis using SMART-MSP and MS-HRM.
Kristensen LS; Wojdacz TK; Thestrup BB; Wiuf C; Hager H; Hansen LL
BMC Cancer; 2009 Dec; 9():453. PubMed ID: 20025721
[TBL] [Abstract][Full Text] [Related]
7. Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer.
Fackler MJ; McVeigh M; Mehrotra J; Blum MA; Lange J; Lapides A; Garrett E; Argani P; Sukumar S
Cancer Res; 2004 Jul; 64(13):4442-52. PubMed ID: 15231653
[TBL] [Abstract][Full Text] [Related]
8. Correlation of apparent diffusion coefficient values measured by diffusion MRI and MGMT promoter methylation semiquantitatively analyzed with MS-MLPA in patients with glioblastoma multiforme.
Sunwoo L; Choi SH; Park CK; Kim JW; Yi KS; Lee WJ; Yoon TJ; Song SW; Kim JE; Kim JY; Kim TM; Lee SH; Kim JH; Sohn CH; Park SH; Kim IH; Chang KH
J Magn Reson Imaging; 2013 Feb; 37(2):351-8. PubMed ID: 23023975
[TBL] [Abstract][Full Text] [Related]
9. Altered methylation at microRNA-associated CpG islands in hereditary and sporadic carcinomas: a methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA)-based approach.
Pavicic W; Perkiö E; Kaur S; Peltomäki P
Mol Med; 2011; 17(7-8):726-35. PubMed ID: 21327300
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of MS-MLPA for detection of MGMT promoter methylation in the evaluation of pseudoprogression in glioblastoma patients.
Park CK; Kim J; Yim SY; Lee AR; Han JH; Kim CY; Park SH; Kim TM; Lee SH; Choi SH; Kim SK; Kim DG; Jung HW
Neuro Oncol; 2011 Feb; 13(2):195-202. PubMed ID: 21075779
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous analysis of the methylation profile of 26 cancer related regions in invasive breast carcinomas by MS-MLPA and drMS-MLPA.
Marzese DM; Gago FE; Vargas-Roig LM; Roqué M
Mol Cell Probes; 2010 Oct; 24(5):271-80. PubMed ID: 20561583
[TBL] [Abstract][Full Text] [Related]
12. Quantitative multiplex methylation-specific PCR analysis doubles detection of tumor cells in breast ductal fluid.
Fackler MJ; Malone K; Zhang Z; Schilling E; Garrett-Mayer E; Swift-Scanlan T; Lange J; Nayar R; Davidson NE; Khan SA; Sukumar S
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3306-10. PubMed ID: 16740751
[TBL] [Abstract][Full Text] [Related]
13. Clonal intratumor heterogeneity of promoter hypermethylation in breast cancer by MS-MLPA.
Moelans CB; de Groot JS; Pan X; van der Wall E; van Diest PJ
Mod Pathol; 2014 Jun; 27(6):869-74. PubMed ID: 24287456
[TBL] [Abstract][Full Text] [Related]
14. Hypermethylated genes as biomarkers of cancer in women with pathologic nipple discharge.
Fackler MJ; Rivers A; Teo WW; Mangat A; Taylor E; Zhang Z; Goodman S; Argani P; Nayar R; Susnik B; Sukumar S; Khan SA
Clin Cancer Res; 2009 Jun; 15(11):3802-11. PubMed ID: 19470737
[TBL] [Abstract][Full Text] [Related]
15. Analysis of RET promoter CpG island methylation using methylation-specific PCR (MSP), pyrosequencing, and methylation-sensitive high-resolution melting (MS-HRM): impact on stage II colon cancer patient outcome.
Draht MX; Smits KM; Jooste V; Tournier B; Vervoort M; Ramaekers C; Chapusot C; Weijenberg MP; van Engeland M; Melotte V
Clin Epigenetics; 2016; 8():44. PubMed ID: 27118999
[TBL] [Abstract][Full Text] [Related]
16. Methylation-specific PCR.
Licchesi JD; Herman JG
Methods Mol Biol; 2009; 507():305-23. PubMed ID: 18987823
[TBL] [Abstract][Full Text] [Related]
17. A closed-tube methylation-sensitive high resolution melting assay (MS-HRMA) for the semi-quantitative determination of CST6 promoter methylation in clinical samples.
Dimitrakopoulos L; Vorkas PA; Georgoulias V; Lianidou ES
BMC Cancer; 2012 Oct; 12():486. PubMed ID: 23088560
[TBL] [Abstract][Full Text] [Related]
18. TIMP3 Promoter Methylation Represents an Epigenetic Marker of BRCA1ness Breast Cancer Tumours.
Maleva Kostovska I; Jakimovska M; Popovska-Jankovic K; Kubelka-Sabit K; Karagjozov M; Plaseska-Karanfilska D
Pathol Oncol Res; 2018 Oct; 24(4):937-940. PubMed ID: 29524167
[TBL] [Abstract][Full Text] [Related]
19. Quantitative promoter hypermethylation profiles of ductal carcinoma in situ in North American and Korean women: Potential applications for diagnosis.
Lee JS; Fackler MJ; Teo WW; Lee JH; Choi C; Park MH; Yoon JH; Zhang Z; Argani P; Sukumar S
Cancer Biol Ther; 2008 Sep; 7(9):1398-406. PubMed ID: 18769130
[TBL] [Abstract][Full Text] [Related]
20. Relevance of MSP assay for the detection of MGMT promoter hypermethylation in glioblastomas.
Yachi K; Watanabe T; Ohta T; Fukushima T; Yoshino A; Ogino A; Katayama Y; Nagase H
Int J Oncol; 2008 Sep; 33(3):469-75. PubMed ID: 18695875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
